Your browser doesn't support javascript.
loading
Phase 1 study of the anti-BCMA antibody-drug conjugate AMG 224 in patients with relapsed/refractory multiple myeloma.
Lee, Hans C; Raje, Noopur S; Landgren, Ola; Upreti, Vijay V; Wang, Jin; Avilion, Ariel A; Hu, Xuguang; Rasmussen, Erik; Ngarmchamnanrith, Gataree; Fujii, Hisaki; Spencer, Andrew.
Afiliação
  • Lee HC; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. hclee@mdanderson.org.
  • Raje NS; Center for Multiple Myeloma, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Landgren O; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, NY, USA.
  • Upreti VV; Clinical Pharmacology Modeling & Simulation, Amgen Inc., South San Francisco, CA, USA.
  • Wang J; Bioanalytical Sciences, Amgen Inc., Thousand Oaks, CA, USA.
  • Avilion AA; Clinical Biomarkers & Diagnostics, Amgen Inc., South San Francisco, CA, USA.
  • Hu X; Clinical Biomarkers & Diagnostics, Amgen Inc., South San Francisco, CA, USA.
  • Rasmussen E; Global Biostatistical Science, Amgen Inc., Thousand Oaks, CA, USA.
  • Ngarmchamnanrith G; Clinical Development, Amgen Inc., Thousand Oaks, CA, USA.
  • Fujii H; Translational Medicine, Amgen Inc., South San Francisco, CA, USA.
  • Spencer A; Malignant Haematology & Stem Cell Transplantation Service, The Alfred Hospital, Monash University, Melbourne, VIC, Australia.
Leukemia ; 35(1): 255-258, 2021 01.
Article em En | MEDLINE | ID: mdl-32317775
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoconjugados / Antígeno de Maturação de Linfócitos B / Antineoplásicos Imunológicos / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Etiology_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoconjugados / Antígeno de Maturação de Linfócitos B / Antineoplásicos Imunológicos / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Etiology_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article